C-reactive protein, inflammation, and coronary risk.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10685132.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Data have revealed interactions between baseline concentration of hs-CRP and the efficacy of common pharmacologic therapies in primary and secondary prevention, suggesting not only that it may be possible to modify the increased risk associated with elevated hs-CRP, but also that inflammatory markers may be useful in targeting preventive therapies. Inflammatory markers may become a valuable component of routine cardiovascular risk assessment.
Medical subject headings
- C-Reactive Protein
- Coronary Artery Disease
- Inflammation
- Myocardial Infarction